Fundz

CEL-SCI Corporation raised $10.8 million in a debt financing offering led by ThinkEquity to fund the continued development of Multikine and for working capital.

PUBLIC · CVMJul 29, 2024

Amount Raised

$10.8 Million

Round Type

Debt Financing

ViennaBiotechnologyHealthcareHealth Care

Investors

Think Equity

Description

CEL-SCI Corporation announced the closing of its best-efforts offering of 10,845,000 shares of common stock for gross proceeds of $10,845,000. The company intends to use the net proceeds from the offering for the development of Multikine and general corporate purposes.

Quick answer

CEL-SCI Corporation raised $10.8 Million in a Debt Financing round, dated July 29, 2024. Investors: Think Equity. CEL-SCI Corporation is based in Vienna, Virginia, United States.

How much did CEL-SCI Corporation raise?
CEL-SCI Corporation raised $10.8 Million in a Debt Financing round on July 29, 2024.
Who invested in CEL-SCI Corporation?
Think Equity is named as investors in this round.
What does CEL-SCI Corporation do?
CEL-SCI is a clinical-stage biotechnology company focused on finding the best way to activate the immune system to fight cancer and infectious diseases.
Where is CEL-SCI Corporation based and how big is it?
CEL-SCI Corporation is based in Vienna, Virginia, United States. Fundz records about 43 employees.
Who are the decision-makers at CEL-SCI Corporation?
Fundz holds 1 contact at CEL-SCI Corporation. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as CEL-SCI Corporation that raised within 45 days of this round, from Fundz verified event records.

  • Oruka Therapeutics raised $200M (Post-IPO Equity) on September 12, 2024.
  • U.S. Renal Care raised $1.3M on September 12, 2024.
  • Pieces Technologies raised $25M (Funding Round) on September 11, 2024.
  • Flyte raised $496K (Seed) on September 3, 2024.
  • Bond Biosciences raised $2.6M (Seed) on August 22, 2024.
  • Endovia Health Sciences, Inc. raised $600K (Seed) on August 22, 2024.

Who to call at CEL-SCI Corporation, and when

A new round usually means CEL-SCI Corporation is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CEL-SCI Corporation raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CEL-SCI Corporation, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CEL-SCI Corporation. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CEL-SCI Corporation

Location

Vienna, Virginia, United States

About

CEL-SCI is a clinical-stage biotechnology company focused on finding the best way to activate the immune system to fight cancer and infectious diseases. The Company’s lead investigational therapy Multikine completed a pivotal Phase 3 clinical trial involving head and neck cancer, for which the Company has received Orphan Drug Status from the FDA. The Company will be commencing a confirmatory trial for Multikine, with enrollment expected to begin in Q4 2024. The Company has operations in Vienna, Virginia, and near Baltimore, Maryland.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CEL-SCI Corporation raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts8 people are listed at CEL-SCI Corporation. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for CEL-SCI Corporation's next move

See what Strategic adds

CEL-SCI Corporation raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.